I believe there was at least one question directed to me, pertaining to my presentation and consultation with the Health Council of Canada. I was invited to make a 45-minute presentation detailing the findings, the peer-reviewed literature, from the scientific evaluation of Insite.
I believe I was asked to characterize the response. It was overwhelmingly positive. Our team was congratulated for producing such a large body of evidence in a short period of time. The medical health officers from different areas of Canada expressed an interest in expressing some kind of support for this initiative. I wasn't privy to exactly what form that would take, but I think it's well known that several medical health officers, including the provincial medical health officer of the province of British Columbia, have been very vocal in their support of this initiative based on the scientific evidence to date.
With regard to the question of the removal of harm reduction from the drug strategy and the release of the anti-drug strategy, no, our group was not consulted on this matter.